21st.BIO A/S — Credit Rating and Financial Key Figures
CVR number: 41554908
Sydmarken 42, 2860 Søborg
info@21st.bio
21st.bio
Income statement (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | -19 455.07 | -21 930.50 | -9 825.86 |
| Employee benefit expenses | -2 808.46 | -16 445.38 | -20 173.63 |
| Total depreciation | -17 071.00 | -18 068.43 | |
| EBIT | -22 263.53 | -55 446.88 | -48 067.92 |
| Other financial income | 85.56 | 304.19 | 7 643.23 |
| Other financial expenses | -80.84 | - 817.65 | -3 224.65 |
| Net income from associates (fin.) | 462.95 | 1 751.68 | -4 818.49 |
| Pre-tax profit | -21 795.86 | -54 208.67 | -48 467.83 |
| Income taxes | 17 596.43 | 6 207.71 | |
| Net earnings | -21 795.86 | -36 612.24 | -42 260.12 |
Assets (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Development expenditure | 9 878.94 | 24 992.36 | |
| Intangible rights | 235 574.58 | 218 747.82 | |
| Intangible assets total | 245 453.52 | 243 740.18 | |
| Buildings | 2 320.86 | 433.90 | |
| Machinery and equipment | 31.92 | 1 607.25 | 1 498.74 |
| Advance payments and construction in progress | 1 495.10 | 1 495.10 | 18 460.27 |
| Tangible assets total | 1 527.02 | 5 423.21 | 20 392.91 |
| Holdings in group member companies | 469.51 | 2 221.20 | |
| Other receivables | 52.20 | 1 211.38 | 1 421.45 |
| Investments total | 521.71 | 3 432.58 | 1 421.45 |
| Long term receivables total | |||
| Inventories total | |||
| Current trade debtors | 33.83 | 2 495.61 | 10 211.62 |
| Current amounts owed by group member comp. | 3 870.34 | 5 208.97 | 43 812.45 |
| Prepayments and accrued income | 1 195.84 | 2 783.23 | |
| Current other receivables | 3 708.86 | 2 467.11 | 3 657.40 |
| Current deferred tax assets | 14 424.59 | 10 307.30 | |
| Short term receivables total | 7 613.04 | 25 792.10 | 70 771.99 |
| Cash and bank deposits | 24 302.54 | 49 286.57 | 82 873.90 |
| Cash and cash equivalents | 24 302.54 | 49 286.57 | 82 873.90 |
| Balance sheet total (assets) | 33 964.31 | 329 387.98 | 419 200.44 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Share capital | 3 229.99 | 10 099.33 | 12 058.09 |
| Asset revaluation reserve | 469.51 | ||
| Other reserves | 2 214.63 | ||
| Retained earnings | 41 950.49 | 286 914.10 | 325 010.79 |
| Profit of the financial year | -21 795.86 | -36 612.24 | -42 260.12 |
| Shareholders equity total | 23 854.14 | 262 615.83 | 294 808.76 |
| Provisions | 54 185.28 | 55 514.22 | |
| Non-current other liabilities | 1 536.00 | ||
| Non-current deferred tax liabilities | 45 000.29 | ||
| Non-current liabilities total | 46 536.29 | ||
| Current loans from credit institutions | 64.00 | ||
| Current trade creditors | 9 054.05 | 5 476.46 | 14 705.82 |
| Current owed to participating | 10.83 | ||
| Other non-interest bearing current liabilities | 1 045.30 | 7 110.41 | 7 571.34 |
| Current liabilities total | 10 110.17 | 12 586.87 | 22 341.16 |
| Balance sheet total (liabilities) | 33 964.31 | 329 387.98 | 419 200.44 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.